Get the Stockscreener App
0.765
5.39%
-0.0436
Mustang Bio Inc stock is traded at $0.765, with a volume of 21,033.
It is down -5.39% in the last 24 hours and down -25.73% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$0.8086
Open:
$0.82
24h Volume:
21,033
Relative Volume:
0.12
Market Cap:
$5.58M
Revenue:
-
Net Income/Loss:
$-1.92M
P/E Ratio:
-1.953
EPS:
-0.3917
Net Cash Flow:
$-5.26M
1W Performance:
-11.01%
1M Performance:
-25.73%
6M Performance:
-52.19%
1Y Performance:
-46.13%
1-Day Range:
$0.76
$0.82
1-Week Range:
$0.76
$0.8969
52-Week Range:
$0.5306
$7.00
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.765 | 5.90M | 0 | -1.92M | -5.26M | -0.3917 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
If You Invested $1,000 in Mustang Bio (MBIO) - Stock Titan
Mustang Bio Inc stock faces prolonged decline amid biotech sector volatility and pipeline uncertaint - AD HOC NEWS
Growth Recap: Whats the profit margin of Mustang Bio Inc2026 Final Week & AI Enhanced Execution Alerts - baoquankhu1.vn
Mustang Bio, Inc. 2025 Annual Report: Clinical-Stage Biopharmaceutical Pipeline, Risks, and Regulatory Overview - Minichart
Mustang Bio 10-K: Net loss narrows to $(1.9)M; cash $17.3M, runway ≥12 months - TradingView
MBIO: 2025 net loss narrowed to $1.9M, cash rose to $17.3M, and liquidity outlook improved after restructuring - TradingView
Mustang Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mustang Bio (NASDAQ: MBIO) details GBM pipeline, Orphan status and cash - Stock Titan
Mustang Bio Inc Stock (ISIN: US62815P1003) Faces Analyst Sell Rating Amid Biotech Volatility - AD HOC NEWS
Mustang Bio Shares Surge After FDA Grants Orphan Drug Status - MSN
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - MSN
Is Mustang Bio Inc. stock a safe buy before earnings2026 Institutional & Verified Technical Trade Signals - Naître et grandir
Buy Signal: Is Cheetah Mobile Inc. Depositary Receipt forming a double bottom2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn
Is NKSH stock vulnerable to regulatory risksPortfolio Performance Report & Safe Entry Trade Reports - Naître et grandir
Sell Signal: Whats the profit margin of Mustang Bio IncDividend Hike & AI Based Trade Execution Alerts - baoquankhu1.vn
MBIO PE Ratio & Valuation, Is MBIO Overvalued - Intellectia AI
Short Interest in Mustang Bio, Inc. (NASDAQ:MBIO) Rises By 405.2% - Defense World
MBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MBIO Should I Buy - Intellectia AI
Critical Contrast: Mustang Bio (NASDAQ:MBIO) & AstraZeneca (NASDAQ:AZN) - Defense World
Market Overview: Is LAND still a buy after recent gainsWeekly Trading Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
MBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MSN Money - MSN
Will CWAN stock boost dividends further2025 Trade Ideas & AI Powered Buy/Sell Recommendations - mfd.ru
Is ARQQ benefiting from interest rate changesStop Loss & Free Daily Entry Point Trade Alerts - mfd.ru
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
T-cell Therapy Market is Expected to Grow USD 15.3 Billion by 2033 | At CAGR 15.11% - vocal.media
US Market Wrap: Will Akoya Biosciences Inc benefit from green energy policiesTreasury Yields & Consistent Growth Stock Picks - baoquankhu1.vn
Glioma Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Aug Setups: Will SHRFP benefit from government policyMarket Growth Review & Growth Oriented Trading Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
How cyclical is Mustang Bio Inc.’s revenue streamMarket Volume Summary & Daily Risk Controlled Trade Plans - mfd.ru
Aug Rallies: Does Mustang Bio Inc have a sustainable dividendEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
MACD Signal: What is OneMain Holdings Incs debt to equity ratioWeekly Profit Summary & Momentum Based Trading Ideas - baoquankhu1.vn
Mustang Bio sells assets and ends lease with AbbVie - MSN
Can Mustang Bio Inc. sustain its profitability2025 Sector Review & Daily Chart Pattern Signals - mfd.ru
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy - The Medicine Maker
CEO Moves: Can Mustang Bio Inc sustain its profitabilityJuly 2025 PostEarnings & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Technicals: Does Mustang Bio Inc have pricing power2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Returns Recap: How is ARRY managing supply chain issues2025 Historical Comparison & Safe Entry Momentum Tips - baoquankhu1.vn
Why millennials buy Thor Industries Inc. stockQuarterly Investment Review & Consistent Return Strategy Ideas - bollywoodhelpline.com
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant
Aug Highlights: What is GDS Holdings Limited Depositary Receipts revenue forecastJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Momentum Screeners Rank Haria Exports Limited in Top 5 TodayEconomic Impact on Stocks & Minimal Investment Trading - Bollywood Helpline
Published on: 2026-01-11 00:49:59 - Bộ Nội Vụ
Why analysts remain bullish on Mustang Bio Inc. stock2025 Volatility Report & High Accuracy Swing Trade Signals - Улправда
How strong dollar benefits Zinc One Resources Inc. (RH3) stock2025 Performance Recap & Stepwise Trade Signal Implementation - Улправда
Will Mustang Bio Inc. stock gain from strong economy2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
2026 world cup match report pre match breakdownBuy Signal & Weekly High Potential Stock Alerts - Улправда
How StealthGas Inc. stock responds to policy changesDay Trade & Risk Controlled Stock Pick Alerts - Улправда
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):